Foghorn Therapeutics

OverviewSuggest Edit

Foghorn Therapeutics discovers and develops novel drugs to treat cancer and other serious medical disorders. It owns and operates Gene Traffic Control, a platform that directs which genes cells express, and when, where, and in what order.
TypePrivate
Founded2016
HQCambridge, US
Websitefoghorntx.com

Latest Updates

Employees (est.) (Nov 2019)84(+7%)

Foghorn Therapeutics Office Locations

Foghorn Therapeutics has an office in Cambridge
Cambridge, US (HQ)
100 Binney St #610
Show all (1)

Foghorn Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Foghorn Therapeutics total Funding

$50 m

Foghorn Therapeutics latest funding size

$50 m

Time since last funding

2 years ago

Foghorn Therapeutics investors

Foghorn Therapeutics's latest funding round in March 2018 was reported to be $50 m. In total, Foghorn Therapeutics has raised $50 m
Show all financial metrics

Foghorn Therapeutics Online and Social Media Presence

Embed Graph

Foghorn Therapeutics Blogs

Foghorn® Therapeutics Expands Leadership Team with Two C-Suite Appointments

Samuel Agresta appointed Chief Medical Officer; Allan Reine to serve as Chief Financial Officer The post Foghorn® Therapeutics Expands Leadership Team with Two C-Suite Appointments appeared first on Foghorn Therapeutics.

Foghorn Therapeutics Frequently Asked Questions

  • When was Foghorn Therapeutics founded?

    Foghorn Therapeutics was founded in 2016.

  • How many employees does Foghorn Therapeutics have?

    Foghorn Therapeutics has 84 employees.

  • Who are Foghorn Therapeutics competitors?

    Competitors of Foghorn Therapeutics include ApoGen Biotechnologies, Taiwan Liposome and Virun.

  • Where is Foghorn Therapeutics headquarters?

    Foghorn Therapeutics headquarters is located at 100 Binney St #610, Cambridge.

  • Where are Foghorn Therapeutics offices?

    Foghorn Therapeutics has an office in Cambridge.

  • How many offices does Foghorn Therapeutics have?

    Foghorn Therapeutics has 1 office.